CHANGHONG TECHNOLOGY(300151)2025-01-19 07:45Financial Performance - Net profit attributable to shareholders of the listed company is expected to be between RMB 90 million and RMB 120 million, representing a year-on-year growth of 184.31% to 279.09%[3] - Non-recurring gains and losses are expected to impact net profit by approximately RMB 23 million, mainly from government subsidies and investment income[6] Business Growth and Expansion - The company's medical device and polymer consumables business, with higher gross margins, continued to grow, contributing to increased profits[5] - The polymer medical consumables industrial park in Zhejiang has been put into use, and the company's medical sector has secured intent orders from three global strategic partners[6] - The company plans to further expand its global production capacity[6] Semiconductor Business Breakthroughs - The semiconductor business achieved breakthroughs in 2024, with FOUP products receiving orders worth several million RMB from a domestic mainstream wafer manufacturer[6]